These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6306098)

  • 41. Antibody isotype responses in the serum and respiratory tract to primary and secondary infections with equine influenza virus (H3N8).
    Hannant D; Jessett DM; O'Neill T; Mumford JA
    Vet Microbiol; 1989 Apr; 19(4):293-303. PubMed ID: 2546319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines.
    Daly JM; Yates RJ; Browse G; Swann Z; Newton JR; Jessett D; Davis-Poynter N; Mumford JA
    Equine Vet J; 2003 Jul; 35(5):458-62. PubMed ID: 12875323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge.
    Chambers TM; Holland RE; Tudor LR; Townsend HG; Cook A; Bogdan J; Lunn DP; Hussey S; Whitaker-Dowling P; Youngner JS; Sebring RW; Penner SJ; Stiegler GL
    Equine Vet J; 2001 Nov; 33(7):630-6. PubMed ID: 11770982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccine failure caused an outbreak of equine influenza in Croatia.
    Barbic L; Madic J; Turk N; Daly J
    Vet Microbiol; 2009 Jan; 133(1-2):164-71. PubMed ID: 18632226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparative antibody study of the potential susceptibility of Thoroughbred and non-Thoroughbred horse populations in Ireland to equine influenza virus.
    Gildea S; Arkins S; Cullinane A
    Influenza Other Respir Viruses; 2010 Nov; 4(6):363-72. PubMed ID: 20958930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Humoral response and antiviral cytokine expression following vaccination of thoroughbred weanlings--a blinded comparison of commercially available vaccines.
    Gildea S; Quinlivan M; Murphy BA; Cullinane A
    Vaccine; 2013 Oct; 31(45):5216-22. PubMed ID: 24021309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of two modern vaccines and previous influenza infection against challenge with an equine influenza virus from the Australian 2007 outbreak.
    Bryant NA; Paillot R; Rash AS; Medcalf E; Montesso F; Ross J; Watson J; Jeggo M; Lewis NS; Newton JR; Elton DM
    Vet Res; 2010; 41(2):19. PubMed ID: 19863903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Duration of the protective immune response after prime and booster vaccination of yearlings with a live modified cold-adapted viral vaccine against equine influenza.
    Tabynov K; Kydyrbayev Zh; Ryskeldinova Sh; Assanzhanova N; Sansyzbay A
    Vaccine; 2014 May; 32(25):2965-71. PubMed ID: 24726250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Study of the duration and distribution of equine influenza virus subtype 2 (H3N8) antigens in experimentally infected ponies in vivo.
    Sutton GA; Viel L; Carman PS; Boag BL
    Can J Vet Res; 1997 Apr; 61(2):113-20. PubMed ID: 9114962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap.
    Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
    Vaccine; 2009 Sep; 27(40):5530-7. PubMed ID: 19607950
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene.
    Lunn DP; Soboll G; Schram BR; Quass J; McGregor MW; Drape RJ; Macklin MD; McCabe DE; Swain WF; Olsen CW
    Vaccine; 1999 May; 17(18):2245-58. PubMed ID: 10403592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The outbreak of equine influenza (H3N8) in the United Kingdom in 1989: diagnostic use of an antigen capture ELISA.
    Livesay GJ; O'Neill T; Hannant D; Yadav MP; Mumford JA
    Vet Rec; 1993 Nov; 133(21):515-9. PubMed ID: 8310627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pro-inflammatory and antiviral cytokine expression in vaccinated and unvaccinated horses exposed to equine influenza virus.
    Quinlivan M; Nelly M; Prendergast M; Breathnach C; Horohov D; Arkins S; Chiang YW; Chu HJ; Ng T; Cullinane A
    Vaccine; 2007 Oct; 25(41):7056-64. PubMed ID: 17825959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination.
    Breathnach CC; Rudersdorf R; Lunn DP
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):127-36. PubMed ID: 15010222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines.
    Mumford JA; Jessett D; Dunleavy U; Wood J; Hannant D; Sundquist B; Cook RF
    Vaccine; 1994 Jul; 12(9):857-63. PubMed ID: 7975864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cross-reactivity of existing equine influenza vaccines with a new strain of equine influenza virus from China.
    Chambers TM
    Vet Rec; 1992 Oct; 131(17):388-91. PubMed ID: 1333665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Equine influenza vaccine efficacy: the significance of antigenic variation.
    Yates P; Mumford JA
    Vet Microbiol; 2000 May; 74(1-2):173-7. PubMed ID: 10799789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Duration of equine influenza virus shedding and infectivity in immunised horses after experimental infection with EIV A/eq2/Richmond/1/07.
    Paillot R; Prowse L; Montesso F; Stewart B; Jordon L; Newton JR; Gilkerson JR
    Vet Microbiol; 2013 Sep; 166(1-2):22-34. PubMed ID: 23769636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccination against equine influenza: quid novi?
    Paillot R; Hannant D; Kydd JH; Daly JM
    Vaccine; 2006 May; 24(19):4047-61. PubMed ID: 16545507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses.
    Chambers TM; Quinlivan M; Sturgill T; Cullinane A; Horohov DW; Zamarin D; Arkins S; García-Sastre A; Palese P
    Equine Vet J; 2009 Jan; 41(1):87-92. PubMed ID: 19301588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.